A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients

Transplant Proc. 1991 Feb;23(1 Pt 2):1050-1.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antilymphocyte Serum / therapeutic use*
  • Cadaver
  • Communicable Diseases / complications
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immunosuppression Therapy / methods*
  • Kidney Transplantation / methods*
  • Muromonab-CD3
  • Prospective Studies
  • Survival Analysis

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Muromonab-CD3